OverviewSuggest Edit

    MDS is a provider of IT solutions. It offers cloud security, identity access management, application and device security, big data and business applications, as well as governance, risk, and compliance services, etc. The company caters to healthcare, government, education, insurance, retail, manufacturing, and other sectors.
    HQNew York, NY, US

    Latest Updates

    Employees (est.) (Jan 2022)84(-1%)
    Cybersecurity ratingBMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    MDS Office Locations

    MDS has an office in New York
    New York, NY, US (HQ)
    500 W 43rd St #33c
    Show all (1)

    MDS Financials and Metrics

    Summary Metrics

    Founding Date


    MDS Cybersecurity Score

    Cybersecurity ratingPremium dataset



    SecurityScorecard logo

    MDS Online and Social Media Presence

    Embed Graph

    MDS News and Updates

    Ardonagh Nears Takeover of Insurance Broker MDS

    Ardonagh Nears Takeover of Insurance Broker MDS

    Aprea Therapeutics Presents Primary Analysis from Phase 2 Trial of Eprenetapopt + Azacitidine for Post-Transplant Maintenance Therapy in TP53 Mutant MDS and AML at the 2021 American Society of Hematology (ASH) Annual Meeting

    BOSTON, Dec. 13, 2021 (GLOBE NEWSWIRE) --  Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53, today announced updated results from its Phase 2 trial evaluatin…

    INmune Bio, Inc. Announces Two Presentations at the 2021 British Society of Immunology Congress and Provides 119-day data on First patient in MDS trial.

    Boca Raton, Florida, Dec. 01, 2021 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced two poster presentations at the 2021 Britis…

    Biosight Announces Initiation of Phase 2 Clinical Trial of Aspacytarabine for MDS and AML

    U.S. Based Phase 2 Trial will Evaluate Aspacytarabine in Second Line Relapsed/Refractory MDS and AML across 18 Sites

    MDS Frequently Asked Questions

    • When was MDS founded?

      MDS was founded in 1994.

    • How many employees does MDS have?

      MDS has 84 employees.

    • Who are MDS competitors?

      Competitors of MDS include Eectacom, PrivateCore and Paralink Networks.

    • Where is MDS headquarters?

      MDS headquarters is located at 500 W 43rd St #33c, New York.

    • Where are MDS offices?

      MDS has an office in New York.

    • How many offices does MDS have?

      MDS has 1 office.